Consolidated Statement Of Cash Flows

Astellas Pharma Inc. - Filing #7358593

Concept As at
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-04-01 to
2023-12-31
2023-10-01 to
2023-12-31
2023-04-01 to
2023-12-31
As at
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
2022-04-01 to
2022-12-31
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
JPY
JPY
JPY
50,323,000,000 JPY
JPY
JPY
JPY
50,323,000,000 JPY
JPY
JPY
JPY
50,323,000,000 JPY
14,513,000,000 JPY
JPY
144,839,000,000 JPY
48,405,000,000 JPY
JPY
JPY
JPY
144,839,000,000 JPY
JPY
JPY
JPY
JPY
JPY
144,839,000,000 JPY
JPY
JPY
Impairment losses (reversal of impairment losses)
13,776,000,000 JPY
24,237,000,000 JPY
Decrease (increase) in inventories
-44,612,000,000 JPY
2,648,000,000 JPY
Other
16,536,000,000 JPY
33,731,000,000 JPY
Subtotal
123,081,000,000 JPY
270,335,000,000 JPY
Income taxes paid
-22,585,000,000 JPY
-58,160,000,000 JPY
Net cash provided by (used in) operating activities
100,496,000,000 JPY
212,174,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-27,527,000,000 JPY
-25,193,000,000 JPY
Purchase of intangible assets
-35,046,000,000 JPY
-35,229,000,000 JPY
Payments for acquisition of subsidiaries
-784,784,000,000 JPY
JPY
Other
6,435,000,000 JPY
-15,819,000,000 JPY
Net cash provided by (used in) investing activities
-823,644,000,000 JPY
-61,781,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-10,734,000,000 JPY
-10,555,000,000 JPY
Other
-7,644,000,000 JPY
-2,276,000,000 JPY
Net cash provided by (used in) financing activities
583,131,000,000 JPY
-91,120,000,000 JPY
Cash and cash equivalents
253,978,000,000 JPY
376,840,000,000 JPY
381,816,000,000 JPY
315,986,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
17,156,000,000 JPY
6,557,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.